Cellular Vaccine Development as Cancer Therapy
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
What are cellular vaccines and how do they differ from what we think of as conventional vaccines? What are the various types of approaches that we can potentially use for inducing anti-cancer immunity? Dr. Don Siegel, vice chair and professor of pathology and laboratory medicine at Penn Medicine, talks with host Dr. Lee Freedman about the exciting potential of cellular vaccines as cancer therapy.
Overview
What are cellular vaccines and how do they differ from what we think of as conventional vaccines? What are the various types of approaches that we can potentially use for inducing anti-cancer immunity? Dr. Don Siegel, vice chair and professor of pathology and laboratory medicine at Penn Medicine, talks with host Dr. Lee Freedman about the exciting potential of cellular vaccines as cancer therapy.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
Partnering with Patients: Building Effective Communication and Support in HF Care
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?